SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Dynavax DVAX
An SI Board Since August 2004
Posts SubjectMarks Bans Symbol
184 23 0 DVAX
Emcee:  keokalani'nui Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
59Dynavax's Two Phase 3 HEPLISAV Trials Cleared by DSMB to Continue to Study CSavant-2/23/2011
58Dynavax Started At Outperform By CowenSavant-2/11/2011
57Dynavax Completes Enrollment for Phase 3 Study of HEPLISAV(TM) in Subjects With Savant-1/10/2011
56Dynavax Reports Phase 1B Safety and Immunogenicity Results for Hepatitis B TheraSavant-12/23/2010
55Dynavax Reports Phase 1a Safety and Immunogenicity Results for Universal Flu VacSavant-12/8/2010
54Just drive-by thinking here (I googled wegener since I was curious). I will asskenhott-3/18/2008
53Not much else came out of the cc. Hard not to feel bad for the company, 2500+ trrkrw-3/18/2008
52<i>that will take a few months or more to sort out</i> But you knowSteve Lokness-3/18/2008
51On the cc dvax said it doesn't seem likely a short, 2 shot vaccine would caurkrw-3/17/2008
50Wegener's halts HEPLISAV after 7years of trials! Ouch! As a shareholder thiSteve Lokness-3/17/2008
49Dynavax Reports Progress in Lupus Program With Inhibitor of TLR7 and TLR9 Mondaytnsaf-11/26/2007
48More news indeed; biz.yahoo.com Dynavax, Merck Partner on Heplisav Thursday NoSteve Lokness-11/1/2007
47Market not impressed, I've bet more news is coming; biz.yahoo.com Selling Steve Lokness-10/23/2007
46Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists Thursdaytnsaf-8/16/2007
45Dynavax Starts HEPLISAV(TM) Phase 3 in Europe; U.S. Study; and Phase 2 in ESRD iLJM-6/26/2007
44BERKELEY, Calif., Jan. 8 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporatkeokalani'nui-1/8/2007
43Dynavax Reports Positive Phase 2a NHL Data at ASH Meeting Sunday December 10, 9:nigel bates-12/10/2006
42Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Shows 100% Seroprotection RegardlLJM-12/4/2006
41Good stuff! edit: they will go after 2 dose. The 3rd dose is a problem in the kenhott-11/29/2006
40It sounds like they will opt for a 3-dose indication in Asia and a 2-dose indicaDewDiligence_on_SI-11/28/2006
39Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Shows Statistically Significant RLJM-11/28/2006
38Dynavax shares surge on news of flu vaccine 8:10pm 10/19/2006 DVAX6.13, -0.42,LJM-10/19/2006
37Dynavax to Show Positive Flu Drug Data Thursday October 19, 6:10 pm ET DynavaxLJM-10/19/2006
36He's Deerfield Capital. Known to be among the best bio investors. They'vrkrw-10/14/2006
35Who is James E Flynn? The guy who bought almost a million shares of DVAX the daSteve Lokness-10/14/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News